Lancora 7.5 mg

Lancora 7.5 mg tablets contain ivabradine, a medication used to manage certain heart conditions. This oral treatment is designed to help regulate heart rate and improve overall cardiovascular function.

Lancora 7.5 mg tablets are primarily used to treat chronic stable angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart. Ivabradine works by reducing the heart rate, which can help alleviate symptoms and improve exercise capacity. This medication is also used in some cases to manage heart failure, where it helps to reduce the heart's workload and improve its efficiency.

Common effects of Lancora 7.5 mg tablets may include temporary visual disturbances such as brightness or halos around lights, dizziness, and headaches. Some users might also experience nausea, fatigue, or a sensation of heart pounding. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Lancora 7.5 mg tablets should be handled with care, especially for individuals with certain medical conditions such as severe liver disease, very low blood pressure, or a history of heart rhythm problems. It is important to follow the prescribed dosage and not to stop taking the medication abruptly without medical advice. Regular monitoring of heart rate and blood pressure is recommended during treatment.

Ivabradine can interact with certain medications, including those that affect heart rate or blood pressure, such as beta-blockers, calcium channel blockers, and some antidepressants. It is also important to avoid grapefruit or grapefruit juice, as they can increase the levels of ivabradine in the body. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.